These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 2749002

  • 1. Disposition of cisplatin derivatives -3H-cis-1,2-diaminocyclohexanedichloroplatinum (II) and 3H-cis-1,2-diaminocyclohexanemalonatoplatinum (II) in BDF1 mice.
    Oswald CB, Wyrick SD, Chaney SG, Shrewsbury RO, Hall IH.
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):41-58. PubMed ID: 2749002
    [Abstract] [Full Text] [Related]

  • 2. Disposition of an antineoplastic sesquiterpene lactone, [3H]-plenolin, in BDF1 mice.
    Grippo AA, Wyrick SD, Lee KH, Shrewsbury RP, Hall IH.
    Planta Med; 1991 Aug; 57(4):309-14. PubMed ID: 1723209
    [Abstract] [Full Text] [Related]

  • 3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
    Cho YB, Kim KH, Kim DK.
    Drug Metab Dispos; 1995 Nov; 23(11):1280-5. PubMed ID: 8591731
    [Abstract] [Full Text] [Related]

  • 5. [The biochemical mechanisms of drug resistance to N-alkyl-N-nitrosoureas and derivatives of cis-dichlorodiammineplatinum].
    Gorbacheva LB.
    Vopr Onkol; 1995 Nov; 41(2):50-1. PubMed ID: 7483435
    [No Abstract] [Full Text] [Related]

  • 6. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E, Chiavarina B, Caviglioli G, Lapide M, Viale M.
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice.
    Kido Y, Khokhar AR, Siddik ZH.
    Drug Metab Dispos; 1992 Oct; 20(5):673-8. PubMed ID: 1358571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacokinetics of new cisplatin analogues in experimental animals].
    Fujita H, Okamoto M, Takao A.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1366-72. PubMed ID: 2658824
    [Abstract] [Full Text] [Related]

  • 10. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL, LeRoy AF, Guarino AM.
    Cancer Treat Rep; 1979 Apr; 63(9-10):1485-92. PubMed ID: 498147
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R, Khokhar AR, Lopez-Berestein G.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [Abstract] [Full Text] [Related]

  • 15. The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum(II) and related derivatives.
    Oswald CB, Hall IH.
    Anticancer Res; 1989 Dec 15; 9(4):915-22. PubMed ID: 2817817
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
    Koenuma M, Kasai H, Uchida N, Wada T, Hattori M, Oguma T, Totani T, Inaba M.
    Anticancer Res; 1995 Dec 15; 15(2):417-21. PubMed ID: 7763015
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distribution of cisplatin in tumor-free versus tumor-bearing B6D2F1 mice.
    Amlacher R, Böckel V, Mackowiak A, Stadeler M, Frankenberg D, Hoffmann H.
    Arch Geschwulstforsch; 1990 Dec 15; 60(5):341-7. PubMed ID: 2241510
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.